Hostname: page-component-586b7cd67f-rcrh6 Total loading time: 0 Render date: 2024-11-28T15:02:14.628Z Has data issue: false hasContentIssue false
  • English
  • Français

Seroprevalence of Chlamydia Pneumoniae Antibodies in Stroke in Young

Published online by Cambridge University Press:  02 December 2014

V. C. S. Srinivasarao Bandaru ,
D. Babu Boddu ,
V. Laxmi ,
M. Neeraja  and
S. Kaul
V. C. S. Srinivasarao Bandaru
Affiliation:
Department of Neurology, Nizam's Institute of Medical Sciences Punjagutta, Hyderabad, India
D. Babu Boddu
Affiliation:
Department of Neurology, Nizam's Institute of Medical Sciences Punjagutta, Hyderabad, India
V. Laxmi
Affiliation:
Department of Microbiology, Nizam's Institute of Medical Sciences Punjagutta, Hyderabad, India
M. Neeraja
Affiliation:
Department of Microbiology, Nizam's Institute of Medical Sciences Punjagutta, Hyderabad, India
S. Kaul*
Affiliation:
Department of Neurology, Nizam's Institute of Medical Sciences Punjagutta, Hyderabad, India
*
Nizam’s Institute of Medical Sciences, Panjagutta, Hyderabad, 500082, India.
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Background:

Younger patients, aged below 45 years, usually lack the conventional risk factors of stroke whereas infections, especially in developing countries, may play a role. There have been many reports in the last decade about the association of Chlamydia pneumoniae (C.pneumoniae) and atherosclerosis involving cerebral vessels.

Objective:

To investigate the seroprevalence of C.pneumoniae IgG and IgA antibodies in patients aged below 45 years with acute ischemic stroke.

Methods:

This study was done at a tertiary care hospital in South India between January 2004 and December 2006 where we recruited consecutive patients aged less than 45years with acute ischemic stroke. Age and sex matched controls were recruited from the outpatient department with non stroke diagnosis. All stroke patients underwent CT (Computerized Tomography), MRI (Magnetic Resonance Image), MRA (Magnetic Resonance Angiography), Transthoracic Echocardiography and Carotid Doppler for stroke sub group diagnosis. We measured C.pneumoniae antibodies IgG and IgA by microimmunofluorescence technique in all patients and controls.

Results:

A total of 120 patients and 120 controls were studied over a period of two years. We found C.pneumoniae antibodies in 29.1% (35/120) stroke patients and in 12.5% (15/120) control subjects (p=0.002). C.pneumoniae IgG antibodies were found in 27.5 % (33/120) of stroke patients and 12.5% (15/120) of controls (p=0.006). IgAantibodies were observed in 5 % (6/120) of strokes and none in control group (p=0.03). After adjustment of all risk factors C.pneumoniae IgG seropositivity showed odds ratio of 2.6; 95% Confidence Interval 1.2-5.6.

Conclusions:

C.pneumoniae IgG antibodies were found to be associated with ischemic stroke in young.

Type
Other
Information
Canadian Journal of Neurological Sciences , Volume 36 , Issue 6 , November 2009 , pp. 725 - 730
Copyright
Copyright © The Canadian Journal of Neurological 2009

References

1.Grayston, JT, Kuo, CC, Wang, SP, Altman, J.A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections. N Engl J Med. 1986;315(3):161–8.CrossRefGoogle ScholarPubMed
2.Campbell, LA, Kuo, CC, Grayston, JT.Chlamydia pneumoniae and cardiovascular disease. Emerging Infect Dis. 1998;4(4):571–9.CrossRefGoogle ScholarPubMed
3.Brassard, P, Bourgault, C, Brophy, J, Suissa, S.Antibiotics in primary prevention of stroke in the elderly. Stroke. 2003;34(9):e163–7.CrossRefGoogle ScholarPubMed
4.Zeman, K, Pospisil, L, Canderle, J, Stroblova, H, Leypold, J, Gregor, Z, et al.Direct and indirect evidence of Chlamydia pneumoniae in patients with significant steonsis of A. carotis of atherosclerotic origin. Script Medica(Brno). 2004;77(3):173–80.Google Scholar
5.Camm, AJ, Fox, KM.Chlamydia pneumoniae (and other infective agents) in atherosclerosis and acute coronary syndromes. Eur Heart J. 2000;21(13):1046–51.CrossRefGoogle ScholarPubMed
6.Shor, A, Phillips, JI.Chlamydia pneumoniae and arthrosclerosis. JAMA. 1999;282(21):2071–3.CrossRefGoogle Scholar
7.Saikku, P, Leinonen, M, Mattila, K, Ekman, MR, Nieminen, MS, Makela, PH.Serological evidence of an association of novel Chlamydia TWAR with chronic coronary heart disease and acute myocardial infarction. Lancet. 1988;2(8618):983–6.CrossRefGoogle ScholarPubMed
8.Elkind, MSV, Lin, IF, Grayston, JT, Sacco, RL.Chlamydia pneumoniae and risk of first ischemic stroke: The Northern Manhattan Stroke Study. Stroke. 2000;31(7):1521–5.CrossRefGoogle ScholarPubMed
9.Danesh, J, Whnicup, P, Lewington, S, Walker, M, Lennon, L, Thomson, A, et al.Chlamydia pneumoniae IgA titers and coronary heart disease. Eur Heart J. 2002;23(5):371–5.CrossRefGoogle ScholarPubMed
10.Melnick, SL, Shahar, E, Folsom, AR, Grayston, JT, Sorlie, PD, Wang, SP, et al.Past infection by Chlamydia pneumoniae strain TWAR and asymptomatic carotid atherosclerosis. Am J Med. 1993;95(5):499–504.CrossRefGoogle ScholarPubMed
11.Grau, AJ, Buggle, F, Ziegler, C, Schwarz, W, Meuser, J, Tasman, AT, et al.Association between acute cerebrovascular ischemia and chronic and recurrent infection. Stroke. 1997;28(9):1724–9.CrossRefGoogle ScholarPubMed
12.Thorvaldsen, P, Asplund, K, Kuulasmaa, K, Rajakangas, AM, Schorll, M.Stroke incidence, case fatality and mortality on the WHO MONICA project. World Health Organization Monitoring Trends and Determinates in Cardiovascular Disease. Stroke. 1995;26(3):361–7.CrossRefGoogle ScholarPubMed
13.Chobanian, AV, Bakris, GL, Balack, HR, Cushman, WC, Green, LA Jr, Izzo, JL, et al.Seventh report of the joint national committee on prevention, detection, evaluation and treatment of high blood pressure. Hypertension. 2003;42(6):1206–52.CrossRefGoogle ScholarPubMed
14.Radhakrishnamurty, B.Diabetes mellitus: In: Heart Disease, Radhakrishnamurty, B, editor. Columbus, GA: Quill Publication; 2003. p. 31–7.Google Scholar
15.Falck, G, Gnarpe, J, Hansson, LO, Svardsudd, K, Gnarpe, H.Comparison of individuals with and without specific IgA antibodies to Chlamydia pneumoniae: respiratory morbidity and the metabolic syndrome. Chest. 2002;122(5):1587–93.CrossRefGoogle ScholarPubMed
16.Saponink, G, Caplan, LR, Gonzalez, LA, Baird, A, Dashe, J, Luraschi, A, et al.Differences in stroke subtypes among natives and Caucasians in Boston and Buenos Aires. Stroke. 2000;31(10):2385–9.Google Scholar
17.Ueland, PM, Refsum, H, Stabler, SP, Malinow, R, Andersson, A, Allen, RH.Total homocysteine in plasma or serum; methods and clinical application. Clin Chemist. 1993;39(9):1764–79.CrossRefGoogle ScholarPubMed
18.Radhakrishnamurty, B.Blood Lipids. In: Heart disease. Radhakrishnamurty, B, editor. Columbus GA: Quill Publication; 2003. p. 18–27.Google Scholar
19.Adams, HP Jr, Bendixen, BH, Kappelle, LJ, Biller, J, Love, BB, Gordon, DL, et al.Classification of subtypes of acute ischemic stroke. Stroke. 1993;24(1):35–41.CrossRefGoogle ScholarPubMed
20.Anzini, A, Cassone, A, Rasura, M, Ciervo, A, Beccia, M, Di Lisi, F, et al.Chlamydia pneumoniae infection in young stroke patients: a case control study. Eur J Neurol. 2004;11(5):321–7.CrossRefGoogle ScholarPubMed
21.Voorend, M, Faber, CG, van der Ven, AJAM, Kessels, F, Bruggeman, CA, Lodder, J.Chlamydia pneumoniae is a likely risk factor for ischemic stroke in young patients. J Stroke Cerbrovasc Dis. 2004;13(2):85–91.CrossRefGoogle ScholarPubMed
22.Wimmer, MLJ, Sandmann-Strupp, R, Saikku, P, Haberl, RL.Association of Chlamydia infection with Cerebrovascular Disease. Stroke. 1996;27(12):2207–10.CrossRefGoogle ScholarPubMed
23.Njamnshi, AK, Blackett, KN, Mbagbaw, JN, Gumedze, F, Gupta, S, Wiysonge, CS.Chronic Chlamydia pneumoniae infection and stroke in Cameroon. Stroke. 2006;37(3);796–9.CrossRefGoogle ScholarPubMed
24.Piechowski-Jozwiak, B, Mickielewicz, A, Gaciong, Z, Berent, H, Kwiecinski, H.Elevated levels of anti-Chlamydia pneumoniae IgA and IgG antibodies in young adults with ischemic stroke. Acta Neurologica Scandinavica. 2007;116(3):144–9.CrossRefGoogle ScholarPubMed
25.Dowell, SF, Boman, J, Carlone, GM, Fields, BS, Guarner, J, Hammerschlag, MR, et al.Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Center for Diseases (Canada). Clin infect Dis. 2001;33(4):492–503.CrossRefGoogle ScholarPubMed
26.Essig, A, Simnaher, U, Susa, M, Marre, R.Analysis of the humoral immune response to Chlamydia pneumoniae by immuno-blotting and immnoprecipitation. Clin Diagn Lab Immunol. 1999;6(6):819–25.CrossRefGoogle Scholar
27.Larsen, MM, Moern, B, Fuller, A, Andersen, PL, Ostergaard, LJ.Chlamydia pneumoniae and cardiovascular disease. Med J Aust. 2002;177(10):558–62.CrossRefGoogle ScholarPubMed
28.Hertzen, LV, Isoaho, R, Kivela, SR, Saikku, P.Finnish study finds significant association between raised IgG, but not IgA, titres and mortality. BMJ. 1999;319(7224):1575–6 (Editorial letter).Google Scholar
29.Agrawal, A, Chander, Y, Nagendra, A.Serological evidence of chronic Chlamydia pneumoniae infection in coronary artery disease. Med J Armed Forces India. 2007;63:229–32.CrossRefGoogle Scholar
30.Bandaru, VCSS, Laxmi, V, Neeraja, M, Alladi, S, Meena, AK, Borgohain, R, et alChlamydia pneumoniae antibodies in various subtypes of ischemic stroke in Indian patients. J Neurol Sci. 2008;272(1-2):115–22.CrossRefGoogle ScholarPubMed
31.Davidson, M, Kuo, CC, Middaugh, JP, Campbell, LA, Wang, SP, Newman, WP III, et al.Confirmed previous infection with Chlamydia pneumoniae (TWAR) and its presence in early coronary atherosclerosis. Circulation. 1998;98(7):628–33.CrossRefGoogle ScholarPubMed
32.Wang, SP.The Microimmunofluorescence test for Chlamydia pneumoniae infection: technique and interpretation. J Infect Dis. 2000:181 Suppl 3:S421–S5.Google Scholar
33.Kol, A, Bourcier, T, Litchman, AH, Libby, P.Chlamydia and human heart shock protein 60s active human vascular endothelium smooth muscles cells, and macrophages. J Clin Invest. 1999;103(4):571–7.CrossRefGoogle Scholar
34.Fryer, RH, Woods, ML, Rogers, GM.Chlamydia species infect human vascular endothelial cells and induce procoagulant activity. J Invest Med. 1997;45(4):168–74.Google ScholarPubMed
35.Young, B, Glesson, M, Cripps, AW.C-reactive protein: a critical review. Pathol. 1991;23(2):118–24.Google ScholarPubMed
36.Ridker, PM.Inflammation, infection, and cardiovascular risk: how good is the clinical evidence? Circulation. 1998;97(17):1671–4.CrossRefGoogle ScholarPubMed
37.Byrne, GI, Kalayoglu, MV.Chlamydia pneumoniae and atherosclerosis: links to the disease process. Am Heart J. 1999;138(5 Pt 2):S448–S90.CrossRefGoogle Scholar